Daicel Corporation Logo

Daicel Corporation

4202.T

(2.2)
Stock Price

1.341,00 JPY

6.64% ROA

16.16% ROE

6.43x PER

Market Cap.

366.968.724.173,00 JPY

78.06% DER

3.91% Yield

9.96% NPM

Daicel Corporation Stock Analysis

Daicel Corporation Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Daicel Corporation Fundamental Stock Analysis
# Analysis Rating
1 Dividend Growth

Investors can take confidence in the company's impressive track record of annual dividend growth over the last five years, showcasing a commitment to rewarding shareholders.

2 ROE

The stock's ROE falls within an average range (13.86%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

3 ROA

The stock's ROA (5.57%) shows that it's doing a pretty good job at making money from its assets, making it a solid choice to invest and earn steady profits.

4 PBV

The stock's PBV ratio (1.46x) reflects a fair valuation, making it an attractive option for investors seeking balanced opportunities.

5 Assets Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

6 Graham Number

The Graham number analysis indicates that this company's stock price is likely undervalued, raising prospects for a favorable investment opportunity.

7 Dividend

Investors can take comfort in the fact that the company has consistently distributed dividends over the past three years, demonstrating a commitment to rewarding shareholders.

8 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock appears undervalued (37.881), presenting an attractive investment chance with its intrinsic value surpassing the current market price.

9 DER

The company has a high debt to equity ratio (103%), which means it owes a lot of money compared to what it actually owns, making it financially risky.

10 Revenue Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

11 Net Profit Growth

This company's net profit has remained stagnant over the past five years, indicating a lack of growth and making it a less favorable investment option.

Daicel Corporation Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Daicel Corporation Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Daicel Corporation Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Daicel Corporation Revenue
Year Revenue Growth
2004 306.335.000.000
2005 335.520.000.000 8.7%
2006 381.422.000.000 12.03%
2007 416.989.000.000 8.53%
2008 377.979.000.000 -10.32%
2009 320.243.000.000 -18.03%
2010 353.684.000.000 9.46%
2011 341.942.000.000 -3.43%
2012 358.513.000.000 4.62%
2013 413.786.000.000 13.36%
2014 443.775.000.000 6.76%
2015 449.878.000.000 1.36%
2016 440.061.000.000 -2.23%
2017 462.956.000.000 4.95%
2018 464.859.000.000 0.41%
2019 412.826.000.000 -12.6%
2020 393.568.000.000 -4.89%
2021 467.937.000.000 15.89%
2022 538.026.000.000 13.03%
2023 560.808.000.000 4.06%
2023 558.056.000.000 -0.49%
2024 582.288.000.000 4.16%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Daicel Corporation Research and Development Expenses
Year Research and Development Expenses Growth
2004 0
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 12.876.000.000 100%
2013 13.360.000.000 3.62%
2014 14.032.000.000 4.79%
2015 15.306.000.000 8.32%
2016 16.806.000.000 8.93%
2017 18.843.000.000 10.81%
2018 20.749.000.000 9.19%
2019 21.295.000.000 2.56%
2020 19.540.000.000 -8.98%
2021 20.741.000.000 5.79%
2022 21.878.000.000 5.2%
2023 0 0%
2023 23.393.000.000 100%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Daicel Corporation General and Administrative Expenses
Year General and Administrative Expenses Growth
2004 0
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 39.359.000.000 100%
2016 40.586.000.000 3.02%
2017 43.547.000.000 6.8%
2018 45.663.000.000 4.63%
2019 44.477.000.000 -2.67%
2020 44.819.000.000 0.76%
2021 47.043.000.000 4.73%
2022 53.267.000.000 11.68%
2023 0 0%
2023 77.048.000.000 100%
2024 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Daicel Corporation EBITDA
Year EBITDA Growth
2004 49.735.000.000
2005 56.638.000.000 12.19%
2006 61.558.000.000 7.99%
2007 60.918.000.000 -1.05%
2008 50.751.000.000 -20.03%
2009 60.103.000.000 15.56%
2010 66.872.000.000 10.12%
2011 51.419.000.000 -30.05%
2012 55.231.000.000 6.9%
2013 67.636.000.000 18.34%
2014 82.072.000.000 17.59%
2015 92.504.000.000 11.28%
2016 98.008.000.000 5.62%
2017 95.251.000.000 -2.89%
2018 85.668.000.000 -11.19%
2019 63.072.000.000 -35.83%
2020 63.282.000.000 0.33%
2021 86.848.000.000 27.13%
2022 85.042.000.000 -2.12%
2023 73.696.000.000 -15.4%
2023 96.096.000.000 23.31%
2024 15.844.000.000 -506.51%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Daicel Corporation Gross Profit
Year Gross Profit Growth
2004 81.011.000.000
2005 86.729.000.000 6.59%
2006 91.860.000.000 5.59%
2007 89.971.000.000 -2.1%
2008 64.864.000.000 -38.71%
2009 69.293.000.000 6.39%
2010 83.893.000.000 17.4%
2011 70.742.000.000 -18.59%
2012 80.869.000.000 12.52%
2013 97.579.000.000 17.12%
2014 116.147.000.000 15.99%
2015 133.829.000.000 13.21%
2016 136.832.000.000 2.19%
2017 137.202.000.000 0.27%
2018 133.773.000.000 -2.56%
2019 111.052.000.000 -20.46%
2020 111.432.000.000 0.34%
2021 138.608.000.000 19.61%
2022 145.812.000.000 4.94%
2023 164.856.000.000 11.55%
2023 159.280.000.000 -3.5%
2024 174.136.000.000 8.53%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Daicel Corporation Net Profit
Year Net Profit Growth
2004 10.844.000.000
2005 14.220.000.000 23.74%
2006 17.438.000.000 18.45%
2007 13.675.000.000 -27.52%
2008 1.296.000.000 -955.17%
2009 11.069.000.000 88.29%
2010 16.802.000.000 34.12%
2011 11.827.000.000 -42.06%
2012 15.372.000.000 23.06%
2013 22.843.000.000 32.71%
2014 31.252.000.000 26.91%
2015 40.313.000.000 22.48%
2016 43.198.000.000 6.68%
2017 37.062.000.000 -16.56%
2018 35.301.000.000 -4.99%
2019 4.978.000.000 -609.14%
2020 19.713.000.000 74.75%
2021 31.254.000.000 36.93%
2022 40.682.000.000 23.17%
2023 59.068.000.000 31.13%
2023 55.834.000.000 -5.79%
2024 64.756.000.000 13.78%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Daicel Corporation Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2004 30
2005 39 25.64%
2006 48 18.75%
2007 38 -29.73%
2008 4 -1133.33%
2009 31 90.32%
2010 47 34.04%
2011 33 -42.42%
2012 44 23.26%
2013 65 32.81%
2014 89 27.27%
2015 115 23.48%
2016 125 7.26%
2017 108 -15.89%
2018 105 -1.9%
2019 15 -600%
2020 65 76.92%
2021 104 37.5%
2022 139 24.64%
2023 207 33.01%
2023 198 -4.57%
2024 235 15.81%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Daicel Corporation Free Cashflow
Year Free Cashflow Growth
2004 16.307.000.000
2005 -26.237.000.000 162.15%
2006 -29.780.000.000 11.9%
2007 2.346.000.000 1369.39%
2008 14.500.000.000 83.82%
2009 48.022.000.000 69.81%
2010 41.677.000.000 -15.22%
2011 16.607.000.000 -150.96%
2012 18.414.000.000 9.81%
2013 16.752.000.000 -9.92%
2014 27.783.000.000 39.7%
2015 29.569.000.000 6.04%
2016 48.155.000.000 38.6%
2017 33.456.000.000 -43.94%
2018 14.944.000.000 -123.88%
2019 10.880.000.000 -37.35%
2020 21.080.000.000 48.39%
2021 -4.478.000.000 570.75%
2022 -25.076.000.000 82.14%
2023 7.521.000.000 433.41%
2023 0 0%
2024 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Daicel Corporation Operating Cashflow
Year Operating Cashflow Growth
2004 41.683.000.000
2005 32.780.000.000 -27.16%
2006 25.534.000.000 -28.38%
2007 49.275.000.000 48.18%
2008 40.165.000.000 -22.68%
2009 66.445.000.000 39.55%
2010 53.428.000.000 -24.36%
2011 34.000.000.000 -57.14%
2012 44.480.000.000 23.56%
2013 44.777.000.000 0.66%
2014 57.412.000.000 22.01%
2015 65.419.000.000 12.24%
2016 86.168.000.000 24.08%
2017 66.888.000.000 -28.82%
2018 58.523.000.000 -14.29%
2019 57.193.000.000 -2.33%
2020 57.869.000.000 1.17%
2021 42.993.000.000 -34.6%
2022 26.847.000.000 -60.14%
2023 76.729.000.000 65.01%
2023 0 0%
2024 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Daicel Corporation Capital Expenditure
Year Capital Expenditure Growth
2004 25.376.000.000
2005 59.017.000.000 57%
2006 55.314.000.000 -6.69%
2007 46.929.000.000 -17.87%
2008 25.665.000.000 -82.85%
2009 18.423.000.000 -39.31%
2010 11.751.000.000 -56.78%
2011 17.393.000.000 32.44%
2012 26.066.000.000 33.27%
2013 28.025.000.000 6.99%
2014 29.629.000.000 5.41%
2015 35.850.000.000 17.35%
2016 38.013.000.000 5.69%
2017 33.432.000.000 -13.7%
2018 43.579.000.000 23.28%
2019 46.313.000.000 5.9%
2020 36.789.000.000 -25.89%
2021 47.471.000.000 22.5%
2022 51.923.000.000 8.57%
2023 69.208.000.000 24.98%
2023 0 0%
2024 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Daicel Corporation Equity
Year Equity Growth
2004 199.837.000.000
2005 228.889.000.000 12.69%
2006 242.407.000.000 5.58%
2007 239.147.000.000 -1.36%
2008 211.487.000.000 -13.08%
2009 229.004.000.000 7.65%
2010 235.336.000.000 2.69%
2011 234.711.000.000 -0.27%
2012 262.898.000.000 10.72%
2013 295.804.000.000 11.12%
2014 356.176.000.000 16.95%
2015 368.720.000.000 3.4%
2016 399.428.000.000 7.69%
2017 413.540.000.000 3.41%
2018 423.242.000.000 2.29%
2019 392.582.000.000 -7.81%
2020 245.000.000.000 -60.24%
2021 279.542.000.000 12.36%
2022 310.433.000.000 9.95%
2023 355.208.000.000 12.61%
2023 374.861.000.000 5.24%
2024 402.446.000.000 6.85%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Daicel Corporation Assets
Year Assets Growth
2004 413.492.000.000
2005 483.468.000.000 14.47%
2006 547.431.000.000 11.68%
2007 515.617.000.000 -6.17%
2008 445.911.000.000 -15.63%
2009 428.376.000.000 -4.09%
2010 411.071.000.000 -4.21%
2011 398.196.000.000 -3.23%
2012 461.512.000.000 13.72%
2013 509.834.000.000 9.48%
2014 565.332.000.000 9.82%
2015 560.190.000.000 -0.92%
2016 599.708.000.000 6.59%
2017 644.078.000.000 6.89%
2018 654.791.000.000 1.64%
2019 597.992.000.000 -9.5%
2020 640.385.000.000 6.62%
2021 698.836.000.000 8.36%
2022 765.606.000.000 8.72%
2023 808.627.000.000 5.32%
2023 839.169.000.000 3.64%
2024 869.500.000.000 3.49%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Daicel Corporation Liabilities
Year Liabilities Growth
2004 213.655.000.000
2005 254.579.000.000 16.08%
2006 305.024.000.000 16.54%
2007 276.470.000.000 -10.33%
2008 234.424.000.000 -17.94%
2009 199.372.000.000 -17.58%
2010 175.735.000.000 -13.45%
2011 163.485.000.000 -7.49%
2012 198.614.000.000 17.69%
2013 214.030.000.000 7.2%
2014 209.156.000.000 -2.33%
2015 191.470.000.000 -9.24%
2016 200.280.000.000 4.4%
2017 230.538.000.000 13.12%
2018 231.549.000.000 0.44%
2019 205.410.000.000 -12.73%
2020 395.385.000.000 48.05%
2021 419.294.000.000 5.7%
2022 455.173.000.000 7.88%
2023 453.419.000.000 -0.39%
2023 464.303.000.000 2.34%
2024 467.054.000.000 0.59%

Daicel Corporation Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
2076.86
Net Income per Share
206.8
Price to Earning Ratio
6.43x
Price To Sales Ratio
0.64x
POCF Ratio
11.58
PFCF Ratio
11.58
Price to Book Ratio
0.95
EV to Sales
1.04
EV Over EBITDA
8.67
EV to Operating CashFlow
18.75
EV to FreeCashFlow
18.75
Earnings Yield
0.16
FreeCashFlow Yield
0.09
Market Cap
366,97 Bil.
Enterprise Value
594,34 Bil.
Graham Number
2549.98
Graham NetNet
-784.46

Income Statement Metrics

Net Income per Share
206.8
Income Quality
0.56
ROE
0.16
Return On Assets
0.07
Return On Capital Employed
0.11
Net Income per EBT
0.74
EBT Per Ebit
1.09
Ebit per Revenue
0.12
Effective Tax Rate
0.25

Margins

Sales, General, & Administrative to Revenue
0.01
Research & Developement to Revenue
0.03
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.3
Operating Profit Margin
0.12
Pretax Profit Margin
0.13
Net Profit Margin
0.1

Dividends

Dividend Yield
0.04
Dividend Yield %
3.91
Payout Ratio
0
Dividend Per Share
52

Operating Metrics

Operating Cashflow per Share
114.93
Free CashFlow per Share
114.93
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.08
Return on Tangible Assets
0.07
Days Sales Outstanding
71.31
Days Payables Outstanding
53.73
Days of Inventory on Hand
168.65
Receivables Turnover
5.12
Payables Turnover
6.79
Inventory Turnover
2.16
Capex per Share
0

Balance Sheet

Cash per Share
266,42
Book Value per Share
1.459,12
Tangible Book Value per Share
1420.04
Shareholders Equity per Share
1397.45
Interest Debt per Share
1096.76
Debt to Equity
0.78
Debt to Assets
0.35
Net Debt to EBITDA
3.31
Current Ratio
2.03
Tangible Asset Value
391,67 Bil.
Net Current Asset Value
-52,89 Bil.
Invested Capital
545489000000
Working Capital
210,61 Bil.
Intangibles to Total Assets
0.01
Average Receivables
113,14 Bil.
Average Payables
60,81 Bil.
Average Inventory
184528000000
Debt to Market Cap
0.82

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Daicel Corporation Dividends
Year Dividends Growth
2001 6
2002 6 0%
2003 6 0%
2004 6 0%
2005 6 0%
2006 8 25%
2007 8 0%
2008 8 0%
2009 8 0%
2010 6 -33.33%
2011 11 45.45%
2012 10 -10%
2013 13 23.08%
2014 17 23.53%
2015 26 34.62%
2016 26 0%
2017 33 21.21%
2018 32 -3.13%
2019 32 0%
2020 18 -77.78%
2021 32 43.75%
2022 34 5.88%
2023 45 24.44%
2024 52 13.46%
2025 0 0%

Daicel Corporation Profile

About Daicel Corporation

Daicel Corporation manufactures and sells cellulosic derivatives, organic chemicals, plastics, pyrotechnic devices, and other products in Japan, Asia, North America, and Europe. It operates through Medical/Healthcare, Smart, Safety, Materials, Engineering Plastics, and Others segments. The company offers 1,3-Butylene glycol, polyglycerin, and thickener for cosmetics; natural health food materials and supplements; and chiral and achiral columns, chiral reagents, bio reagents, and DNA and RNA-based probes, as well as analytical/purification/synthesis/formulation services, and analytical tools services for pharmaceuticals. It also provides triacetylcellulose and films for display market; solvent for electronic materials, polymers for resist, and semiconductor process cleaning agents; and optical parts and lens units, silver nanoparticle inks, and organic semiconductor devices for visualization technology. In addition, the company offers inflators for air bags and pyro-fuse for automotive market, as well as safety device for non-mobility products; acetic acid and derivatives, cellulose acetate, acetate tow, and other raw materials for resins and inks, and solvents for paints; and cycloaliphatic epoxies, caprolactone, ketene derivatives, alkylamines, and other raw materials for electrical materials and coatings. Further, it provides a range of plastics, such as engineering plastics, plastic compound products, functional sheets, formed trays, and packaging films for engineering plastics segment. Additionally, the company manufactures and distributes water treatment systems and diffusers for a range of industrial applications. Its products are used in transportation, electronics, medical care, personal care, everyday life, and environment and energy applications. The company was formerly known as Daicel Chemical Industries, Ltd. and changed its name to Daicel Corporation in October 2011. Daicel Corporation was incorporated in 1919 and headquartered in Osaka, Japan.

CEO
Mr. Yoshimi Ogawa
Employee
11.134
Address
Grand Front Osaka Tower-B
Osaka, 530-0011

Daicel Corporation Executives & BODs

Daicel Corporation Executives & BODs
# Name Age
1 Seiji Yamakado
Executive Officer & Head of Customer Center
70
2 Ikuo Takahashi
Executive officer, GM of Innovation Park & Head of Corporate Reserch Center
70
3 Mr. Yasuhiro Sakaki
Senior Managing Executive Officer, GM of Corporate Strategy & SCM Division and Director
70
4 Mr. Yoshimi Ogawa
President, Chief Executive Officer & Director
70
5 Mr. Kotaro Sugimoto
Senior Managing Executive Officer, Head of Corporate Support Headquarters & Director
70
6 Naotaka Kawaguchi
Managing Executive Officer
70
7 Masaaki Fujio
Executive Officer & Head of Responsible Care
70
8 Naohide Hakushi
Managing Executive Officer, GM of Himeji Production Sector & Aboshi Plant
70
9 Hidekage Kojima
Senior Managing Executive Officer
70
10 Takashi Ueno
Managing Executive Officer, Head of Production Management Headquarters & GM of Ohtake Plant
70

Daicel Corporation Competitors